Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity

Hypertension

Volumn 27, Issue 5, 1996, Pages 1180-1186

  Ikeda, Toshio ^a,b   Gomi, Tomoko ^a   Hirawa, Nobuhito ^a   Sakurai, Jun ^a   Yoshikawa, Nori ^a  

^a NTT CORPORATION   (Japan)

^b Kanto Teishin Hospital   (Japan)

Author keywords

body mass index; diet; hypertension, obesity; insulin resistance; norepinephrine; renin angiotensin system

Indexed keywords

ALDOSTERONE; GLUCOSE; INSULIN; ISOPHANE INSULIN; NORADRENALIN; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NORADRENALIN BLOOD LEVEL; OBESITY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WEIGHT REDUCTION;

EID: 0029914535     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.5.1180     Document Type: Article

References (46)

1. Chiang BN, Perlman LV, Epstein FH. Overweight and hypertension. Circulation. 1969;39:403-421.
2. Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RH. Weight and blood pressure: findings in hypertension screening of 1 million Americans. JAMA. 1978;240:1607-1610.
3. Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med. 1985;103:983-988.
4. Reisin E, Frohlich ED, Messerli FH, Dreslinski GR, Dunn FG, Jones MM, Batson HM Jr. Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med. 1983;98:315-319.
5. Raison J, Achimastos A, Bouthier J, London G, Safar M. Intravascular volume, extracellular fluid volume, and total body water in obese and nonobese hypertensive patients. Am J Cardiol. 1983;51: 165-170.
6. Rocchini AP, Moorehead C, Katch V, Key J, Finta KM. Forearm resistance vessel abnormalities and insulin resistance in obese adolescents. Hypertension. 1992;19:615-620.
7. Sowers JR, Whitfield LA, Catania RA, Stern N, Tuck ML, Dornfeld L. Maxwell M. Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab. 1982;54:1181-1186.
8. Sowers JR, Nyby M, Stern N, Beck F, Baron S, Catania R, Vlachis N. Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension. 1982;4:686-691.
9. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med. 1981; 304:930-933.
10. Marks P, Wilson B, Delassalle A. Aldosterone studies in obese patients with hypertension. Am J Med Sci. 1985;289:224-228.
11. Lucas CP, Estigarribia JA, Darga LL, Reaven GM. Insulin and blood pressure in obesity. Hypertension. 1985;7:702-706.
12. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab. 1986;62:1302-1304.
13. Rocchini AP, Katch V, Schork A, Kelch RP. Insulin and blood pressure during weight loss in obese adolescents. Hypertension. 1987;10:267-273.
14. Caro JF. Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab. 1991;73:691-695.
15. Dengel DR, Pratley RE, Hagberg JM, Goldberg AP. Impaired insulin sensitivity and maximal responsiveness in older hypertensive men. Hypertension. 1994;23:320-324.
16. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism. 1990;39:167-174.
17. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317: 350-357.
18. WHO Study Group. Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1985:10-14. WHO Technical Reporl Series 727.
19. Guidelines Sub-Committee of the WHO/ISH Mild Hypertension Liaison Committee. 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. WHO Bulletin OMS. 1993;71:503-517.
20. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
21. Maxwell MH, Kushiro T, Dornfeld LP, Tuck ML, Waks AU. BP changes in obese hypertensive subjects during rapid weight loss: comparison of restricted v unchanged salt intake. Arch Intern Med. 1984;144:1581-1584.
22. Fagerberg B, Andersson OK, Persson B, Hedner T. Reactivity to norepinephrine and effect of sodium on blood pressure during weight loss. Hypertension. 1985;7:586-592.
23. Young JB, Landsberg L. Diet-induced changes in sympathetic nervous system activity: possible implications for obesity and hypertension. J Chron Dis. 1982;35:879-886.
24. Jung RT, Shelly PS, Barrand M, Callingham BA, James WPT. Role of catecholamines in hypotensive response to dieting. Br Med J. 1979;1:12-13.
25. Andersson B, Elam M, Wallin BG, Björntorp P, Andersson OK. Effect of energy-restricted diet on sympathetic muscle nerve activity in obese women. Hypertension. 1991;18:783-789.
26. Weinsier RL, James LD, Darnell BE, Dustan HP, Birch R, Hunter GR. Obesity-related hypertension: evaluation of the separate effects of energy restriction and weight reduction on hemodynamic and neuroendocrine status. Am J Med. 1991;90:460-468.
27. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol. 1981;240:E630-E639.
28. Bratusch-Marrain PR, Smith D, DeFronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab. 1982;55:973-982.
29. Laakso M, Unsitupa M, Takala J, Majander H, Reijonen T, Penttilä I. Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects. Metabolism. 1988;37:1092-1100.
30. Wolpert HA, Steen SN, Istfan NW, Simonson DC. Disparate effects of weight loss on insulin sensitivity and erythrocyte sodium-lithium countertransport activity. Am J Hypertens. 1992;5:754-757.
31. Franssila-Kallunki A, Rissanen A, Ekstrand A, Ollus A, Groop L. Effects of weight loss on substrate oxidation, energy expenditure, and insulin sensitivity in obese individuals. Am J Clin Nutr. 1992;55: 356-361.
32. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 1981;30:219-225.
33. Anderson EA, Balon TW, Huffman RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension. 1992;19:621-627.
34. Berne C, Fagius J, Pollare T, Hjemdahl P. The sympathetic response to euglycemic hyperinsulinaemia. Diabetologia. 1992;35: 873-879.
35. DeFronzo RA. The effect of insulin on renal sodium metabolism. Diabetologia. 1981;21:165-171.
36. Gans ROB, Toorn L, Bilo HJG. Nauta JJP, Heine RJ, Donker AJM. Renal and cardiovascular effects of exogenous insulin in healthy volunteers. Clin Sci. 1991;80:219-225.
37. Hall JE, Coleman TG, Mizelle HL, Smith MJ. Chronic hyperinsulinemia and blood pressure regulation. Am J Physiol. 1990;258: F722-F731.
38. Edwards JG, Tipton CM. Influences of exogenous insulin on arterial blood pressure measurements of the rat. J Appl Physiol. 1989;67: 2335-2342.
39. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am. J Physiol. 1991;260:R764-R768.
40. Moreau P, Lamarche L, Laflamme AK, Calderone A, Yamaguchi N, de Champlain J. Chronic hyperinsulinaemia and hypertension: the role of the sympathetic nervous system. J Hypertens. 1995;13: 333-340.
41. Julius S, Gudbrandsson T, Jamerson K, Shahab ST, Andersson O. The hemodynamic link between insulin resistance and hypertension. J Hypertens. 1991;9:983-986.
42. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension. 1993;21:129-135.
43. Moan A, Nordby G, Rostrup M, Eide I, Kjeldsen SE. Insulin sensitivity, sympathetic activity, and cardiovascular reactivity in young men. Am J Hypertens. 1995;8:268-275.
44. Jacobs DB, Sowers JR, Hmeidan A, Niyogi T, Simpson L, Standley PR. Effects of weight reduction on cellular cation metabolism and vascular resistance. Hypertension. 1993;21:308-314.
45. Fagerberg B, Berglund A, Andersson OK, Berglund G. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids. J Hypertens. 1992;10:1053-1061.
46. Puddey IB, Parker M, Beilin LJ, Vandongen R, Masarei JRL. Effects of alcohol and caloric restrictions on blood pressure and serum lipids in overweight men. Hypertension. 1992;20:533-541.